Co-Diagnostics (CODX) reported third-quarter 2026 revenue of $282,881, compared with $145,380 a year earlier. The company recorded a net loss of $6.3 million, or $1.01 per basic and diluted share, for the quarter ended September 30.
Operating expenses declined to $6.2 million from $7.1 million in the prior-year quarter. Co-Diagnostics also reported regulatory submissions under review in the United States and India for its respiratory and tuberculosis tests.
- Total revenue was $282,881, up from $145,380 in the third quarter of 2025.
- Net loss was $6.31 million, compared with a $5.89 million net loss a year earlier.
- Operating expenses were $6.25 million, down from $7.13 million.
- Cash and cash equivalents totaled $714,803 as of September 30, 2026.
- After quarter end, the company completed a senior secured convertible debt financing with approximately $2.1 million in initial funding before transaction expenses.
- The company submitted a 510(k) notification and concurrent CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV test and submitted its CoSara PCR MTB test to India’s CDSCO.
$CODX Hedge Fund Activity
We have seen 16 institutional investors add shares of $CODX stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 236,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $731,600
- JANE STREET GROUP, LLC added 89,240 shares (+inf%) to their portfolio in Q2 2026, for an estimated $276,644
- MILLENNIUM MANAGEMENT LLC added 31,995 shares (+inf%) to their portfolio in Q2 2026, for an estimated $99,184
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 31,239 shares (+inf%) to their portfolio in Q2 2026, for an estimated $96,840
- CITIGROUP INC added 25,301 shares (+inf%) to their portfolio in Q3 2026, for an estimated $27,072
- GEODE CAPITAL MANAGEMENT, LLC added 24,024 shares (+93.9%) to their portfolio in Q3 2026, for an estimated $25,705
- VIRTU FINANCIAL LLC added 17,612 shares (+inf%) to their portfolio in Q2 2026, for an estimated $54,597
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.